Gemcitabine-Cisplatin Regimen

Known as: gemcitabine/cisplatin regimen 
A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2018
01220012018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Cytotoxic chemotherapy has been the mainstay of medical therapy for metastatic urothelial cancer. Currently, the gemcitabine… (More)
Is this relevant?
2006
2006
The impact of adjuvant chemotherapy in locally advanced bladder cancer is still not fully established. Between January 2000 and… (More)
Is this relevant?
2005
2005
BACKGROUND Although platinum-based chemotherapy has become a standard treatment for non-small cell lung cancer (NSCLC), its… (More)
Is this relevant?
2004
2004
The clinical case of a 73-year-old man with a history of transitional cell carcinoma of the bladder, an ulcerated mass on the… (More)
Is this relevant?
2004
2004
8155 AIM: This Prospective Phase II study was undertaken to determine whether a dose-modified gemcitabine-cisplatin regimen… (More)
Is this relevant?
2002
2002
BACKGROUND New chemotherapeutic agents, including paclitaxel and gemcitabine, are active in advanced bladder carcinoma, and… (More)
Is this relevant?
Review
2001
Review
2001
The necessity of improving the long-term survival of patients with locally advanced non-small cell lung cancer (NSCLC) points out… (More)
Is this relevant?